Cited by 1,524Viral-associated cancers and disordersTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Open access

Engels, Eric A., Pfeiffer, Ruth M., Fraumeni, Joseph F., Kasiske, Bertram L., Israni, Ajay K., Snyder, Jon J., Wolfe, Robert A., Goodrich, Nathan P., Bayakly, A. Rana, Clarke, Christina A., Copeland, Glenn, Finch, Jack L., Fleissner, Mary Lou, Goodman, Marc T., Kahn, Amy, Koch, Lori, Lynch, Charles F., Madeleine, Margaret M., Pawlish, Karen, Rao, Chandrika, Williams, Melanie A., Castenson, David, Curry, Michael, Parsons, Ruth, Fant, Gregory, Lin, Monica·2011·JAMA

DOI 10.1001/jama.2011.1592PMC PMC3310893

Open this paper in CoChat — free account

Abstract

CONTEXT: Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. OBJECTIVE: To describe the overall pattern of cancer following solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. MAIN OUTCOME MEASURES: Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. RESULTS: The registry linkages yielded data on 175,732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10,656 cases and an incidence of 1375 per 100,000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100,000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100,000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100,000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100,000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100,000 person-years), liver (n = 930; incidence: 120.0 per 100,000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100,000 person-years), and kidney (n = 752; incidence: 97.0 per 100,000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100,000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). CONCLUSION: Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2011.1592

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test
Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S. A., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,173
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,321
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Overdiagnosis in Cancer
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,627
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312

Show all 43 references

Sorted by citations

Items 501–600 of 1,000

Renal cell cancer after kidney transplantation
Kleine-Döpke, D., Oelke, M., Schwarz, A., Schwager, Y., Lehner, F., Klempnauer, J. L., & Schrem, H. (2018) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-018-1694-x · Cited by 17
Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience
Teo, S. M., Lee, K., Lim, G. H., Koo, S., Ramirez, M., Chow, K., & Kee, T. Y. S. (2018) · Singapore Medical Journal · doi:10.11622/smedj.2018122 · Cited by 17
Solid organ transplant rejection associated with immune-checkpoint inhibitors
Saberianfar, S., Nguyen, L. S., Manouchehri, A., Lebrun‐Vignes, B., Moslehi, J. J., Johnson, D. B., Hertig, A., & Salem, J. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.01.012 · Cited by 18
Characteristics and outcomes of lung cancer in solid organ transplant recipients
Chen, L. N., Spivack, J., Cao, T., Saqi, A., Benvenuto, L. J., Bulman, W. A., Mathew, M., Stoopler, M. B., Arcasoy, S. M., Stanifer, B. P., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.06.018 · Cited by 17
Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts
Ge, F., Li, C., Xu, X., Huo, Z., Wang, R., Wen, Y., Peng, H., Wu, X., Liang, H., Peng, G., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3525 · Cited by 17
The head and neck cancer genome in the era of immunotherapy
Wijetunga, N. A., Yu, Y., Morris, L. G. T., Lee, N. Y., & Riaz, N. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105040 · Cited by 17
Solid Organ Transplantation and Survival among Individuals with a History of Cancer
Engels, E. A., Haber, G., Hart, A., Lynch, C. F., Li, J., Pawlish, K. S., Qiao, B., Yu, K. J., & Pfeiffer, R. M. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0044 · Cited by 17
Self-citation
Cancer co-occurrence patterns in Parkinson’s disease and multiple sclerosis—Do they mirror immune system imbalances?
Ajdacic‐Gross, V., Rodgers, S., Aleksandrowicz, A., Mütsch, M., Steinemann, N., von Wyl, V., von Känel, R., & Bopp, M. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.08.018 · Cited by 17
Cancers solides après transplantation d’organe : épidémiologie, pronostic et spécificités de prise en charge
Guillemin, A., Rousseau, B., Neuzillet, C., Joly, C., Boussion, H., Grimbert, P., Compagnon, P., Duvoux, C., & Tournigand, C. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2016.12.008 · Cited by 17
Risk of malignancy in patients with psoriasis: a 15‐year nationwide population‐based prospective cohort study in Korea
Lee, J. W., Jung, K. J., Kim, T., Lee, M., Oh, J., Jee, S. H., & Lee, M. G. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15783 · Cited by 17
Integrating mixed reality, augmented reality, and artificial intelligence in complex liver surgeries: Enhancing precision, safety, and outcomes
Wang, X., Yang, J., Zhou, B., Tang, L., & Liang, Y. (2025) · iLiver · doi:10.1016/j.iliver.2025.100167 · Cited by 16
Management of de-novo urothelial carcinoma in transplanted patients
Pradère, B., Schuettfort, V. M., Mori, K., Quhal, F., Aydh, A., & Motlagh, R. S. (2020) · Current Opinion in Urology · doi:10.1097/mou.0000000000000749 · Cited by 16
Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance
Datta, R. R., Schran, S., Persa, O.-D., Aguilar, C., Thelen, M., Lehmann, J., Garcia-Marquez, M. A., Wennhold, K., Preugszat, E., Zentis, P., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3746 · Cited by 16
Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period
Piselli, P., Serraino, D., Cimaglia, C., Furian, L., Biancone, L., Busnach, G., Bossini, N., Todeschini, P., Iaria, M., Citterio, F., et al. (2023) · Cancers · doi:10.3390/cancers15041347 · Cited by 16
Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression
Chauvelot, L., Barba, T., Saison, C., Siska, E., Kulifaj, D., Bakker, S. J. L., Koenig, A., Rabeyrin, M., Buron, F., Picard, C., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29806 · Cited by 16
De novo thyroid cancer following solid organ transplantation—A 25‐year experience at a high‐volume institution with a review of the literature
Kluijfhout, W. P., Drake, F. T., Pasternak, J. D., Beninato, T. M., Mitmaker, E. J., Gosnell, J. E., Shen, W. T., Suh, I., Freise, C. E., & Duh, Q. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24495 · Cited by 16
Successful treatment of primary donor‐derived human herpesvirus‐8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient
Fu, W. W., Merola, J., Malinis, M. F., Lacy, J., Barbieri, A., Liapakis, A., Mulligan, D. C., & Yoo, P. S. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12966 · Cited by 16
Cumulative radiation dose after lung transplantation in patients with cystic fibrosis
Fitton, I., Revel, M., Burgel, P., Hernigou, A., Boussaud, V., Guillemain, R., Pimpec‐Barthes, F. L., Bennani, S., Freche, G., Frija, G. G., et al. (2019) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2018.12.006 · Cited by 16
Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp
Paoluzzi, L., & Ow, T. J. (2021) · Current Oncology · doi:10.3390/curroncol28010057 · Cited by 16
Establishment of Chimerism and Organ Transplant Tolerance in Laboratory Animals: Safety and Efficacy of Adaptation to Humans
Lowsky, R., & Strober, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.805177 · Cited by 16
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
Franco, P., Segelov, E., Johnsson, A., Riechelmann, R. P., Guren, M. G., Das, P., Rao, S., Arnold, D., Spindler, K. G., Deutsch, É., et al. (2022) · Cancers · doi:10.3390/cancers14071697 · Cited by 16
Oral potentially malignant disorders: advice on management in primary care
Eccles, K., Carey, B., Cook, R., Escudier, M., Freitas, M. D., Posse, J. L., Monteiro, L. S., Silva, L., Fricain, J., Catros, S., et al. (2022) · Journal of Oral Medicine and Oral Surgery · doi:10.1051/mbcb/2022017 · Cited by 16
Melanoma in Organ Transplant Recipients: Incidence, Outcomes and Management Considerations
Ali, F. R., & Lear, J. T. (2012) · Journal of Skin Cancer · doi:10.1155/2012/404615 · Cited by 17
Risk of cancer after lung transplantation for COPD
Ekström, M. P., Riise, G. C., & Tanash, H. A. (2017) · International Journal of COPD · doi:10.2147/copd.s147065 · Cited by 16
Myeloid Neoplasms Following Solid Organ Transplantation
Wu, B., Ingersoll, K., Jug, R. C., Yang, L.-H., Luedke, C., Lo, A., Su, P., Liu, X., Rehder, C. W., Gong, J. Z., et al. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx133 · Cited by 16
Sedentary Behaviour and Cancer
Lynch, B. M., Mahmood, S., & Boyle, T. (2017) · Springer series on epidemiology and public health · doi:10.1007/978-3-319-61552-3_10 · Cited by 17
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions
NIKE Group, Gallo, M., Guarnotta, V., de Cicco, F., Rubino, M., Faggiano, A., & Colao, A. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02839-w · Cited by 16
High‐Intensity Focused Ultrasonography and Radiofrequency Ablation of Renal Cell Carcinoma Arisen in Transplanted Kidneys: Single‐Center Experience With Long‐Term Follow‐Up and Review of Literature
Candio, G. D., Porcelli, F., Campatelli, A., Guadagni, S., Vistoli, F., & Morelli, L. (2019) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14938 · Cited by 16
“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”
Wareham, N. E., Li, Q., Sengeløv, H., da Cunha‐Bang, C., Gustafsson, F., Heilmann, C. J., Perch, M., Rasmussen, A., Sørensen, S. S., Mocroft, A., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03039-2 · Cited by 16
De novo and recurrent malignancy
Shalaby, S., & Burra, P. (2020) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2020.101680 · Cited by 16
Screening colonoscopy in liver transplant candidates: risks and findings
Weismüller, T. J., Bleich, F., Negm, A. A., Schneider, A. S., Lankisch, T. O., Manns, M. P., Strassburg, C. P., & Wedemeyer, J. (2013) · Clinical Transplantation · doi:10.1111/ctr.12083 · Cited by 16
Cancer diagnosis in a cohort of patients with Sjogren's syndrome and rheumatoid arthritis: a single-center experience and review of the literature.
Boussios, S., Pentheroudakis, G. E., Somarakis, G., Markatseli, T. E., Drosos, A. A., & Pavlidis, N. A. (2014) · PubMed · Cited by 16
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs
Bechman, K., Song, K., Abhishek, A., Adas, M. A., Ahmed, A., Bray, L., Davidson, A., Deepak, S., Dey, M., Vere, H. D., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf522 · Cited by 15
Implications of cancer prior to and after heart transplantation
Mudigonda, P., Berardi, C., Chetram, V., Barac, A., & Cheng, R. K.-H. (2021) · Heart · doi:10.1136/heartjnl-2020-318139 · Cited by 15
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder
Lee, M., Abousaud, A. I., Harkins, R. A., Marin, E. M., Balasubramani, D., Churnetski, M. C., Peker, D., Singh, A. K., & Koff, J. L. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01418-0 · Cited by 15
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion
Watt, K. D., Rolak, S. C., Foley, D. P., Plichta, J. K., Pruthi, S., Farr, D., Zwald, F. O., Carvajal, R. D., Dudek, A. Z., Sanger, C. B., et al. (2024) · Transplantation · doi:10.1097/tp.0000000000005056 · Cited by 15
Recomendaciones para el uso de everolimus en trasplante renal de novo: falsas creencias, mitos y realidades
Pascual, J., Diekmann, F., Fernández-Rivera, C., Gómez, G., Gutiérrez-Dalmau, Á., Pérez‐Sáez, M. J., Calabuig, A. S., & Oppenheimer, F. (2017) · Nefrología · doi:10.1016/j.nefro.2016.11.007 · Cited by 15
Intravesical bacillus Calmette-Guérin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation
Swietek, N., Waldert, M., Susani, M., Schatzl, G., & Klatte, T. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0343-1 · Cited by 15
Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture
Tanner, J. E., Hu, J. S., & Alfieri, C. (2018) · Cancers · doi:10.3390/cancers10040112 · Cited by 15
Incidence, Management, and Clinical Outcomes of Prostate Cancer in Kidney Transplant Recipients
Haroon, U., Davis, N. F., Mohan, P., Little, D. M., Smyth, G. P., Forde, J., & POWER, R. E. (2019) · Experimental and Clinical Transplantation · doi:10.6002/ect.2018.0048 · Cited by 15
Prostate Cancer Screening and Management in Solid Organ Transplant Candidates and Recipients.
Becher, E., Wang, A. Y., & Lepor, H. (2019) · PubMed Central · Cited by 15
Immune-Checkpoint Inhibitors in Renal Transplanted Patients Affected by Melanoma: A Systematic Review
Rossi, E., Schinzari, G., Maiorano, B. A., Esposito, I., Acampora, A., Romagnoli, J., Stefani, A. D., Regno, L. D., Lancellotta, V., Fionda, B., et al. (2021) · Immunotherapy · doi:10.2217/imt-2021-0195 · Cited by 15
[Retracted] Current Status of Malignant Tumors after Organ Transplantation
Shen, B., Cen, Z., Tan, M., Song, C., Wu, X., Wang, J., & Huang, M. (2022) · BioMed Research International · doi:10.1155/2022/5852451 · Cited by 15
Retracted
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years
Vergote, V. K. J., Deroose, C. M., Fieuws, S., Laleman, W., Sprangers, B., Uyttebroeck, A., Cleemput, J. V., Verhoef, G. E. G., Vos, R., Tousseyn, T., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10707 · Cited by 15
Management of de novo malignancies after liver transplantation
Pillai, A. A. (2014) · Transplantation Reviews · doi:10.1016/j.trre.2014.11.002 · Cited by 15
Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia
Verran, D. J., Mulhearn, M. H., Dilworth, P., Balderson, G. A., MUNN, S. R., Chen, J. W., Fink, M. A., Crawford, M. D., & McCaughan, G. W. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10102 · Cited by 15
Immunotherapy: a new standard of care in thoracic malignancies?
Costantini, A., Grynovska, M., Lucibello, F., Moisés, J., Pagès, F., Tsao, M., Shepherd, F. A., Bouchaab, H., Garassino, M. C., Aerts, J. G. J. V., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02072-2017 · Cited by 15
Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection
Ros, J., Matos, I. G., & Martín-Liberal, J. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz129 · Cited by 15
The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages
Zheng, T., Zhu, C., Bassig, B. A., Liu, S., Buka, S. L., Zhang, X., Truong, A., Jun-hi, O. H., Fulton, J. P., Dai, M., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz136 · Cited by 15
Elevated incidence of head and neck cancer in solid organ transplant recipients
Mowery, A. J., Conlin, M. J., & Clayburgh, D. R. (2019) · Head & Neck · doi:10.1002/hed.25937 · Cited by 15
Pembrolizumab: the value of PDL1 biomarker in head and neck cancer
Addeo, R., Caraglia, M., & Iuliano, G. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1211635 · Cited by 15
Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus
Hsu, Y.-C., Chen, C., Huang, H., Lee, Y.-T., Wu, M.-C., Su, C.-W., Chou, H.-C., Wang, L., Lee, M., Lin, S., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004425 · Cited by 14
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Yanagita, M., Muto, S., Nishiyama, H., Ando, Y., Hirata, S., Doi, K., Fujiwara, Y., Hanafusa, N., Hatta, T., Hoshino, J., et al. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02415-0 · Cited by 14
Renal transplant complications
Weber, T. M., & Lockhart, M. E. (2013) · Abdominal Imaging · doi:10.1007/s00261-013-0005-9 · Cited by 14
Renal Pretransplantation Work-up, Donor, Recipient, Surgical Techniques
Harmath, C. B., Wood, C. G., Berggruen, S., & Tantisattamo, E. (2016) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2015.09.006 · Cited by 14
Tracing the Equilibrium Phase of Cancer Immunoediting in Epidermal Neoplasms via Longitudinal Intravital Imaging
Kubick, B. J., Fan, X., Crouch, A., McCarthy, R., & Roop, D. R. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.446 · Cited by 16
Post-transplant malignancies in alcoholic liver disease
Singh, A., De, A., & Singh, V. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.11.18 · Cited by 15
Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada
Park, C. K., Dahlke, E. J., Fung, K., Kitchen, J., Austin, P. C., Rochon, P. A., & Chan, A. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.09.072 · Cited by 14
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor
Hofmann, J. N., Landgren, O., Landy, R., Kemp, T. J., Santo, L., McShane, C. M., Shearer, J. J., Qing Lan, B., Rothman, N., Pinto, L. A., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz104 · Cited by 14
Self-citation
Gastroenterological complications in kidney transplant patients
Calogero, A., Gallo, M., Sica, A., Peluso, G., Scotti, A., Tammaro, V., Carrano, R., Federico, S., Lionetti, R., Amato, M., et al. (2020) · Open Medicine · doi:10.1515/med-2020-0130 · Cited by 14
Sirolimus in renal transplant recipients with malignancies in Germany
Naik, M. G., Arns, W., Budde, K., Diekmann, F., Eitner, F., Gwinner, W., Heyne, N., Jürgensen, J. S., Morath, C. P., Riester, U., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa262 · Cited by 14
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review
Feng, G., Li, Q., Zhu, H., Jiang, Y., Yuan, J., Fu, Y., & Deng, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.726134 · Cited by 14
A review of the mutagenic potential of N‐ethyl‐N‐nitrosourea (ENU) to induce hematological malignancies
Nath, P., & Maiti, D. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23067 · Cited by 14
Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy
Luu, Y. T., Luo, Q., Horner, M., Shiels, M. S., Engels, E. A., & Sargen, M. R. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.09.008 · Cited by 14
Self-citation
Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
Bhat, M., & Watt, K. D. S. (2015) · Clinical Transplantation · doi:10.1111/ctr.12559 · Cited by 14
Exposure to Ionizing Radiation During Liver Transplantation Evaluation, Waitlist Time, and in the Postoperative Period: A Cause for Concern
Lee, S. Y., Mooney, M. A., Inra, M. L., Juluru, K., Fox, A. N., Olsen, S. K., Brown, R. S., Emond, J. C., Cherqui, D., & Kluger, M. D. (2013) · Hepatology · doi:10.1002/hep.26633 · Cited by 14
Tumores urológicos de novo en pacientes trasplantados renales
Faba, O. R., Breda, A., Gausa, L., Palou, J., & Villavicencio, H. (2014) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2014.05.002 · Cited by 14
Is Thyroid Cancer Recurrence Risk Increased After Transplantation?
Tisset, H., Kamar, N., Faugeron, I., Roy, P., Pouteil‐Noble, C., Klein, M., Mourad, G., Drui, D., Cao, C. D., Leenhardt, L., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1357 · Cited by 14
Mutations in components of antiviral or microbial defense as a basis for breast cancer
Friedenson, B. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0336-1 · Cited by 14
Immune Checkpoint Therapy in Head and Neck Cancers
Msaouel, P., & Massarelli, E. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000180 · Cited by 14
Hemophagocytic Lymphohistiocytosis Due to Primary HHV-8 Infection in a Liver Transplant Recipient
Cohen, G. M., Langer, A. L., Sima, H. R., Chang, C., Troy, K. M., & Taimur, S. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000850 · Cited by 14
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas
Bertz, S., Ensser, A., Stoehr, R., Eckstein, M., Apel, H., Mayr, D. C., Buettner-Herold, M., Gaisa, N. T., Compérat, É., Wullich, B., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0489-0 · Cited by 14
Kidney Transplantation in Patients with HIV
Sawinski, D. L. (2020) · Kidney360 · doi:10.34067/kid.0002112020 · Cited by 14
Lung cancer screening with low-radiation dose computed tomography after liver transplantation
Zulueta, J. J. (2013) · Annals of Transplantation · doi:10.12659/aot.884021 · Cited by 14
Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program
Wang, H., Chen, X., Zhao, J., Kang, M., Dong, R., Wang, K., & Qu, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.921859 · Cited by 14
Development of Phenotyping Algorithms for the Identification of Organ Transplant Recipients: Cohort Study
Wheless, L., Baker, L. X., Edwards, L. D., Anand, N. C., Birdwell, K. A., Hanlon, A. M., & Chren, M. (2020) · JMIR Medical Informatics · doi:10.2196/18001 · Cited by 13
Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management
Carbone, A., Chadburn, A., Gloghini, A., Vaccher, E., & Bower, M. (2024) · Blood Reviews · doi:10.1016/j.blre.2023.101167 · Cited by 13
Melanoma — Epidemiology, Genetics and Risk Factors
John, A., Jarrett, S. G., Marsch, A. F., Lagrew, J. P., & Cleary, L. C. (2013) · InTech eBooks · doi:10.5772/55172 · Cited by 16
Cohort Profile: The Skin Cancer After Organ Transplant Study
Madeleine, M. M., Johnson, L., Daling, J. R., Schwartz, S. M., Carter, J. J., Berg, D., Nelson, K., Davis, C. L., & Galloway, D. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys179 · Cited by 13
Self-citation
Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey
Karakoyun, M., Göktepe, Ş. Ö., Baran, M., Çakır, M., Ecevıt, Ç. Ö., Kılıç, M., Kantar, M., Aksoylar, S., Özgenç, F., & Aydoğdu, S. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2017.17089 · Cited by 13
Clinicopathologic Characterization of Post–Renal Transplantation BK Polyomavirus-Associated Urothelial CarcinomaSingle Institutional Experience
Chu, Y., Zhong, W., Rehrauer, W. M., Pavelec, D. M., Ong, I. M., Djamali, A., Patel, S. S., & Hu, R. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz167 · Cited by 13
Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft
Warren, H. R., & Olsburgh, J. (2020) · Current Urology Reports · doi:10.1007/s11934-020-0959-4 · Cited by 13
Vitamin K and Kidney Transplantation
Fusaro, M., Cosmai, L., Evenepoel, P., Nickolas, T. L., Cheung, A. M., Aghi, A., Tripepi, G. L., Plebani, M., Iervasi, G., Vettor, R., et al. (2020) · Nutrients · doi:10.3390/nu12092717 · Cited by 13
Transplant of Elderly Patients
Cottone, C., Polanco, N. A. P., & Bhamidimarri, K. R. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.09.001 · Cited by 13
The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients
Taborelli, M., Serraino, D., Cimaglia, C., Furian, L., Biancone, L., Busnach, G., Todeschini, P., Bossini, N., Iaria, M., Campise, M., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16825 · Cited by 13
Malignancy: An Adverse Effect of Immunosuppression
Munagala, M. R., & Phancao, A. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_554 · Cited by 14
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Fang, H., Yan, H. H. N., Bilardi, R. A., Flensburg, C., Yang, H., Barbour, J. A., Siu, H. C., Turski, M. L., Chew, E., Xu, Z., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01131-w · Cited by 13
Immune checkpoint inhibitors in kidney transplantation
Alzahrani, N., Jurdi, A. A., & Riella, L. V. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001036 · Cited by 14
Immunotherapy and Liver Transplantation
Tabrizian, P., Yu, A. T., Debnath, N., Myers, B., & Marron, T. U. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.07.009 · Cited by 13
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
Joo, V., Abdelhamid, K., Noto, A., Latifyan, S., Martina, F., Daoudlarian, D., Micheli, R. D., Pruijm, M. T., Peters, S., Hullin, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47965-3 · Cited by 13
Islet transplantation in type 1 diabetes: hype, hope and reality – a clinician's perspective
Zinger, A., & Leibowitz, G. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2484 · Cited by 13
Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation
Baychelier, F., Achour, A., Nguyen, S., Raphaël, M., Toubert, A., Besson, C., Arnoux, A., Roos‐Weil, D., Marty, M. E., Chapelier, A. R., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.038 · Cited by 13
A review of nationwide population study of organ transplantation in Taiwan
Tsai, H., & Yu, H. (2016) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2016.05.003 · Cited by 13
Incidence of melanoma in organ transplant recipients in Alberta, Canada
Tran, M., Sander, M. A., Ravani, P., & Mydlarski, P. R. (2016) · Clinical Transplantation · doi:10.1111/ctr.12818 · Cited by 13
Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients
Tsai, Y. F., Chen, H. P., Liu, F.-C., Liu, S.-H., Chen, C. Y., Cheng, C. W., & Lin, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11965 · Cited by 13
Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?
Lim, W. H., Au, E. H. K., Krishnan, A., & Wong, G. (2019) · Transplant International · doi:10.1111/tri.13486 · Cited by 13
The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy
Melaragno, J. I., Bowman, L. J., Park, J. M., Lourenço, L. M., Doligalski, C. T., Brady, B. L., Descourouez, J. L., Chandran, M. M., Nickels, M. W., & Page, R. L., II (2020) · Transplantation · doi:10.1097/tp.0000000000003309 · Cited by 13
Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study
Minguito‐Carazo, C., Gómez-Bueno, M. F., Bonet, L. A., Barge‐Caballero, E., González-Vílchez, F., Delgado, J. F., del Prado, J. M. A., Sousa-Casasnovas, I., Mirabet, S., González‐Costello, J., et al. (2021) · Transplant International · doi:10.1111/tri.13827 · Cited by 13
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant
Nada, A., & Jetton, J. G. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05172-y · Cited by 13
Equal 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With Cirrhosis
Parsikia, A., Campos, S., Khanmoradi, K., Pang, J. H., Balasubramanian, M., Zaki, R. F., & Ortiz, J. (2015) · International Surgery · doi:10.9738/intsurg-d-13-00231.1 · Cited by 13

Authors: Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., Copeland, G., Finch, J. L., Fleissner, M. L., Goodman, M. T., Kahn, A., Koch, L., Lynch, C. F., Madeleine, M. M., Pawlish, K., Rao, C., Williams, M. A., Castenson, D., Curry, M., Parsons, R., Fant, G., & Lin, M.
Affiliations: National Institutes of Health (US)
Arbor Research Collaborative for Health (US)
Cancer Prevention Institute of California (US)
Michigan Department of Health and Human Services (US)
Connecticut Agricultural Experiment Station (US)
University of Hawaiʻi at Mānoa (US)
Illinois Department of Public Health (US)
University of Iowa (US)
Fred Hutch Cancer Center (US)
New Jersey Department of Health (US)
Texas Department of State Health Services (US)
Information Management Services (US)
United States Department of Health and Human Services (US)
Corresponding author: Engels, Eric A.
ORCID: Engels, Eric A.
Pfeiffer, Ruth M.
Kasiske, Bertram L.
Israni, Ajay K.
Snyder, Jon J.
Goodrich, Nathan P.
Clarke, Christina A.
Copeland, Glenn
Finch, Jack L.
Goodman, Marc T.
Kahn, Amy
Lynch, Charles F.
Madeleine, Margaret M.
Pawlish, Karen
Rao, Chandrika
Castenson, David
Curry, Michael
Fant, Gregory
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2011-11-02
Volume: 306
Issue: 17
Pages: 1891
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2011.1592
PMC: PMC3310893
OpenAlex: W1964106115
Cited by: 1,524
References: 43
Citations by year: 2026: 83 · 2025: 100 · 2024: 100 · 2023: 89 · 2022: 106 · 2021: 114 · 2020: 134 · 2019: 124 · 2018: 107 · 2017: 114 · 2016: 108 · 2015: 106 · 2014: 97 · 2013: 83 · 2012: 55
FWCI: 37.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01pc54405-9-0-0, n01pc35143-20-0-1, n01pc35139-25-0-11, n01pc35142-19-0-0, n01pc35137-18-0-2)
National Cancer Institute (N01PC35139, HHSN261201000034 C, HHSN261201000036C, HHSN261201000035C, N01‐PC035137, N01 PC035143, N01 PC35142, HHSN261201000037C, N01-PC-54405, HHSN261201000035I, N01-PC-35 137, N01PC-35143, N01 PC035139, HHSN261201000024C, N01 PC035142, N01 PC054405, ZIACP010150)
National Center for Chronic Disease Prevention and Health Promotion (5U58DP000824-04, 5U58DP000812-03, U58 DP000812, U58 DP000817, U58 DP000805, U58 DP000807, U58 DP000848-04, U58 DP000832, 5U58DP000817-05, U58 DP000824, U58/DP000808, #1U58DP000807-01, 5658DP 000805-04, U58 DP000848, 5U58/DP000808-03)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: solid organ transplant recipients, cancer risk, immunosuppression, non-Hodgkin lymphoma, lung cancer, Kaposi's sarcoma, anal cancer, melanoma, thyroid cancer, lip cancer, hepatitis C, cytomegalovirus, Epstein-Barr virus, post-transplant lymphoproliferative disorder
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Immune Tolerance, Infant, Male, Middle Aged, Neoplasms, Registries, Risk, United States, Cohort Studies, Incidence, Organ Transplantation, Immunocompromised Host, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks